Ebola treatments: trials stopped early for benefit tend to overestimate the effects of the intervention
A recent news item in The BMJ1 reported that a trial of the antiviral vaccines mAB114 and REGN-EB3 was ended prematurely because it met early stopping criteria for effectiveness. This is encouraging…
